WPRIM Management System> DCMS> China Oncology> 2015> > 1

Volume: Issue: 1

1. Establishment of daily quality assurance program and analysis of dosimetric characteristics’ long- term stability for mobile intraoperative radiation therapy accelerator Page:52—56
2. Comparison of clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women Page:21—28
3. The heterogenous expression and signiifcance of multidrug resistance-associated proteins in primary tumors and metastatic lymph nodes in patients with esophageal squamous cell carcinoma Page:15—20
4. Association between microRNA expression and chemotherapy in colorectal cancer Page:62—68
5. Prediction of peripheral blood lymphocytes radiosensitivity in normal tissue radiation damage in oncology patients with radiotherapy Page:57—61
6. S-1 plus oxaliplatin for the treatment of advanced small bowel adenocarcinoma Page:46—51
7. Expression of serum TK1 in human breast tumor and its clinical significance Page:41—45
8. The effects and mechanisms of Gankyrin silencing on reversing the cisplatin resistance of human ovarian cancer SKOV3/DDP cell line Page:35—40
9. The radiosensitizing effects of cryptotanshinone on H22 hepatoma-bearing mice Page:29—34
10. The expression of ABCC4/MRP4 and ABCC5/MRP5 gene in the NK/T cell lymphoma and its relationship with clinical efifcacy Page:8—14
11. Expression and clinical signiifcance of PAK5 protein expression in osteosarcoma Page:1—7
12. Quantitative analysis of LMX1A and PAX1 gene methylation in cervical cancer and cervical intraepithelial neoplasia Page:19—24
13. Expression of CCL26 in esophageal squamous cell carcinoma tissues and its clinical significance Page:13—18
14. Silencing of miR-21 influences the function of colon cancer cell line HT-29 and the expression of PDCD4 Page:6—12
15. The role of gap junctions composed of connexin 43 on the anti-tumor effect induced by etoposide Page:1—5
16. Update on the molecular targeted therapy for cervical cancer Page:73—80
17. The survey of cancer treatment model and staging in mainland China Page:67—72
18. Clinical observation of albumin-bound paclitaxel plus S-1 in patients with advanced pancreatic cancer after the failure of gemcitabine Page:63—66
19. Analysis of the effects of different treatment methods in patients with stage Ⅰb2 bullky cervical cancer Page:56—62
20. The clinical analysis of retreatment with erlotinib in advanced non-small cell lung cancer Page:50—55
21. Distribution of 5-FU in rat hepatoma, liver tissue and plasma after locoregional infusion Page:45—49
22. Resistance reverse effect of anemoside B4 and tetrandrine on oxaliplatin-resistant human colon cancer cells and the mechanism Page:38—44
23. Effects of oridonin on cytoskeletal protein F-actin in human pancreatic carcinoma cells Page:31—37
24. The role ofΔ133p53 during 5-FU inhibition experiments on the growth of gastric cancer cell line MKN45 Page:25—30
25. Risk factors of lymph node metastasis in cN0 papillary thyroid carcinoma Page:73—79
26. Pay attention to the problem of the overtreatment of thyroid nodules Page:43—46
27. Re-differentiating therapy of radioiodine-refractory differentiated thyroid cancer Page:35—42
28. Long noncoding RNAs in urological neoplasms Page:117—120
29. Advances in research on ultrasound-guided percutaneous ethanol injection for treatment of benign cystic thyroid nodules Page:112—116
30. Preoperative prediction and intraoperative injury prevention of nonrecurrent laryngeal nerve Page:107—111
31. Diagnosis and treatment of papillary thyroid micro-carcinoma:An analysis of 61 cases Page:102—106
32. Cervical ultrasound and thyroglobulin in diagnosis of recurrence of differentiated thyroid carcinoma Page:97—101
33. 18F-FDG PET/CT imaging in the monitoring of response to sorafenib in patients with radioiodine- refractory differentiated thyroid cancer Page:88—96
34. The impact of lymph node metastatic rate on clinical outcome following131I therapy in patients with papillary thyroid carcinoma Page:67—72
35. The value of three-dimensional Doppler angiography in the differentiation of benign and malignant thyroid nodules Page:60—66
36. The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:Ultrasound part Page:19—24
37. Analysis of the clinicopathological characteristics for 1 306 cases of thyroid cancer in Qingdao Page:53—59
38. Distribution and risk factors of thyroid cancer in China Page:47—52
39. The molecular-targeted therapy in advanced differentiated thyroid cancer Page:31—34
40. Circulating RNA in thyroid cancer Page:25—30
41. The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:Surgery part Page:13—18
42. The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma:New progress in radioactive iodine therapy of differentiated thyroid carcinoma Page:1—12